[go: up one dir, main page]

MX2007010895A - Procedimiento para la purificacion de compuestos benzoxazol substituidos. - Google Patents

Procedimiento para la purificacion de compuestos benzoxazol substituidos.

Info

Publication number
MX2007010895A
MX2007010895A MX2007010895A MX2007010895A MX2007010895A MX 2007010895 A MX2007010895 A MX 2007010895A MX 2007010895 A MX2007010895 A MX 2007010895A MX 2007010895 A MX2007010895 A MX 2007010895A MX 2007010895 A MX2007010895 A MX 2007010895A
Authority
MX
Mexico
Prior art keywords
purification
benzoxazole compounds
substituted benzoxazole
compound
solution
Prior art date
Application number
MX2007010895A
Other languages
English (en)
Inventor
Silvio Iera
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MX2007010895A publication Critical patent/MX2007010895A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/42One oxygen atom attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion proporciona un procedimiento para la purificacion de compuestos benzoxazol sustituidos de la formula (I), y, en particular el 2-(3-fluoro-4-hidroxi-fenil)-7-vinil- benzoxazol-5-ol; el procedimiento incluye la recristalizacion del compuesto desde una solucion que comprende acetona y acetonitrilo; tratando el producto purificado crudo con un agente clarificante en una solucion que comprende acetato de etilo, y precipitar o triturar el compuesto desde un sistema de mezcla de solventes.
MX2007010895A 2005-03-07 2006-03-06 Procedimiento para la purificacion de compuestos benzoxazol substituidos. MX2007010895A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65921205P 2005-03-07 2005-03-07
PCT/US2006/007887 WO2006096624A1 (en) 2005-03-07 2006-03-06 Process for the purification of substituted benzoxazole compounds

Publications (1)

Publication Number Publication Date
MX2007010895A true MX2007010895A (es) 2007-12-05

Family

ID=36579426

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007010895A MX2007010895A (es) 2005-03-07 2006-03-06 Procedimiento para la purificacion de compuestos benzoxazol substituidos.

Country Status (20)

Country Link
US (1) US7579478B2 (es)
EP (1) EP1856068A1 (es)
JP (1) JP2008531748A (es)
KR (1) KR20070111515A (es)
CN (1) CN101128443A (es)
AR (1) AR052934A1 (es)
AU (1) AU2006220680A1 (es)
BR (1) BRPI0607816A2 (es)
CA (1) CA2601975A1 (es)
GT (1) GT200600104A (es)
IL (1) IL185146A0 (es)
MX (1) MX2007010895A (es)
NI (1) NI200700206A (es)
NO (1) NO20074103L (es)
PA (1) PA8665701A1 (es)
PE (1) PE20061181A1 (es)
RU (1) RU2007130408A (es)
SG (1) SG160352A1 (es)
TW (1) TW200643017A (es)
WO (1) WO2006096624A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080146630A1 (en) * 2006-11-21 2008-06-19 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080139633A1 (en) * 2006-11-21 2008-06-12 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080132554A1 (en) * 2006-11-21 2008-06-05 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080176914A1 (en) * 2006-11-21 2008-07-24 Wyeth Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
CA2601973A1 (en) * 2005-03-07 2006-09-14 Wyeth Process for the preparation of substituted benzoxazole compounds

Also Published As

Publication number Publication date
NI200700206A (es) 2008-07-03
KR20070111515A (ko) 2007-11-21
US7579478B2 (en) 2009-08-25
AR052934A1 (es) 2007-04-11
PE20061181A1 (es) 2006-12-19
GT200600104A (es) 2006-10-25
US20060199967A1 (en) 2006-09-07
EP1856068A1 (en) 2007-11-21
CN101128443A (zh) 2008-02-20
WO2006096624A1 (en) 2006-09-14
IL185146A0 (en) 2007-12-03
SG160352A1 (en) 2010-04-29
NO20074103L (no) 2007-12-05
AU2006220680A1 (en) 2006-09-14
TW200643017A (en) 2006-12-16
BRPI0607816A2 (pt) 2010-03-23
PA8665701A1 (es) 2007-01-17
JP2008531748A (ja) 2008-08-14
CA2601975A1 (en) 2006-09-14
RU2007130408A (ru) 2009-04-20

Similar Documents

Publication Publication Date Title
WO2009023179A3 (en) Nitrogen containing bicyclic chemical entities for treating viral infections
WO2008055870A8 (en) Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2008034859A8 (en) Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
BR0313265A (pt) Compostos e respectivos processos de preparação, uso e formulações farmacêuticas e métodos de prevenção e/ou tratamento de distúrbios mediados por receptor mglur5 e de inbição da ativação de receptores mglu r5.
IN2015DN02325A (es)
TW200745037A (en) Organic compounds
MY148982A (en) Phenyl-1,2,4-oxadiazolone derivative with phenyl group, processes for their preparation and their use as pharmaceuticals
BR0314611A (pt) Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
MY157860A (en) Prevention and treatment of secondary infections following viral infection
MX2008000255A (es) Activadores de urea glucocinasa.
WO2004037789A3 (en) Methylene urea derivatives as raf-kinase inhibitors
TW200510333A (en) Benzimidazole compounds
WO2004094386A8 (en) Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
WO2009040314A3 (de) Neue heteroarylsubstituierte acetonderivate, geeignet zur hemmung der phospholipase a2
MX2009002998A (es) Derivado de pirazolopirimidina.
MY149070A (en) 1h-quinazoline-2,4-diones
MX2007010895A (es) Procedimiento para la purificacion de compuestos benzoxazol substituidos.
AU2001260077A1 (en) Microfiltration using activated carbon
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
SI1831239T1 (sl) Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
WO2007057767A3 (en) Amino acid derivatives
TW200716521A (en) Substituted aryl oximes
WO2009075857A3 (en) Glycine transporter-1 inhibitors
TW200722435A (en) Purification of proteins with cationic surfactant